Literature DB >> 8279321

The mucopolysaccharidoses: characterization by cranial MR imaging.

C Lee1, T E Dineen, M Brack, J E Kirsch, V M Runge.   

Abstract

PURPOSE: To characterize MR findings in mucopolysaccharidoses (MPS), to aid in diagnosis and categorization, and to define the role of MR in preoperative evaluation.
MATERIALS AND METHODS: Six children with Hurler syndrome (MPS IH), five with Hunter syndrome (MPS II), and three with Sanfilippo A syndrome (MPS IIIA) were studied by routine T1-weighted and T2-weighted images at 1.5 T. MR findings were graded retrospectively.
RESULTS: All had hallmark cribriform changes (sieve-like or multicystic) involving peri- and supraventricular, parietal, white matter (12), corpus callosum (8), and basal ganglia (4), which did not enhance. The cerebellum and brain stem were not involved with these cribriform changes. The most severe degree of cribriform changes occurred in children with Hunter and Hurler syndromes, correlating with non-central nervous system somatic involvement, but inversely related to degree of atrophy, ventricular enlargement, and white matter changes. Mental retardation was most severe in children with Hurler syndrome and correlated with chronicity of the disease. Severity of mental retardation did not correlate with severity of cribriform changes.
CONCLUSIONS: Based on our observations, we postulate that in the natural course of MPS, cribriform changes occurred first, followed by white-matter changes and, last, atrophy. More severe degrees of cribriform changes plus involvement of the corpus callosum may suggest a poorer prognosis. Optimal therapeutic intervention may be at the time of cribriform changes before atrophy has occurred. MR can define and grade these changes.

Entities:  

Mesh:

Year:  1993        PMID: 8279321

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  32 in total

Review 1.  Pictorial review of mucopolysaccharidosis with emphasis on MRI features of brain and spine.

Authors:  D D Rasalkar; W C W Chu; J Hui; C-M Chu; B K Paunipagar; C-K Li
Journal:  Br J Radiol       Date:  2011-05       Impact factor: 3.039

2.  Brain MRI findings in patients with mucopolysaccharidosis types I and II and mild clinical presentation.

Authors:  M Gisele Matheus; Mauricio Castillo; J Keith Smith; Diane Armao; Diane Towle; Joseph Muenzer
Journal:  Neuroradiology       Date:  2004-06-17       Impact factor: 2.804

3.  Cerebral magnetic resonance findings during enzyme replacement therapy in mucopolysaccharidosis.

Authors:  Yoshiko Matsubara; Osamu Miyazaki; Motomichi Kosuga; Torayuki Okuyama; Shunsuke Nosaka
Journal:  Pediatr Radiol       Date:  2017-07-21

Review 4.  Brain and spinal MR imaging findings in mucopolysaccharidoses: a review.

Authors:  D I Zafeiriou; S P Batzios
Journal:  AJNR Am J Neuroradiol       Date:  2012-07-12       Impact factor: 3.825

Review 5.  Virchow-Robin spaces on magnetic resonance images: normative data, their dilatation, and a review of the literature.

Authors:  Samuel Groeschel; Wui Khean Chong; Robert Surtees; Folker Hanefeld
Journal:  Neuroradiology       Date:  2006-08-05       Impact factor: 2.804

6.  High-resolution magnetic resonance microscopy and diffusion tensor imaging to assess brain structural abnormalities in the murine mucopolysaccharidosis VII model.

Authors:  Manoj Kumar; Ilya M Nasrallah; Sungheon Kim; Ranjit Ittyerah; Stephen Pickup; Joel Li; Michael K Parente; John H Wolfe; Harish Poptani
Journal:  J Neuropathol Exp Neurol       Date:  2014-01       Impact factor: 3.685

Review 7.  Mucopolysaccharidoses: overview of neuroimaging manifestations.

Authors:  Manal Nicolas-Jilwan; Moeenaldeen AlSayed
Journal:  Pediatr Radiol       Date:  2018-05-11

8.  Features of brain MRI in dogs with treated and untreated mucopolysaccharidosis type I.

Authors:  Charles H Vite; Igor Nestrasil; Anton Mlikotic; Jackie K Jens; Elizabeth M Snella; William Gross; Elsa G Shapiro; Victor Kovac; James M Provenzale; Steven Chen; Steven Q Le; Shih-hsin Kan; Shida Banakar; Raymond Y Wang; Mark E Haskins; N Matthew Ellinwood; Patricia I Dickson
Journal:  Comp Med       Date:  2013-04       Impact factor: 0.982

9.  Hunter syndrome in an 11-year old girl on enzyme replacement therapy with idursulfase: brain magnetic resonance imaging features and evolution.

Authors:  Renzo Manara; Angelica Rampazzo; Mara Cananzi; Leonardo Salviati; Rodica Mardari; Paola Drigo; Rosella Tomanin; Nicoletta Gasparotto; Elena Priante; Maurizio Scarpa
Journal:  J Inherit Metab Dis       Date:  2010-01-06       Impact factor: 4.982

Review 10.  In Vivo NMR Studies of the Brain with Hereditary or Acquired Metabolic Disorders.

Authors:  Erica B Sherry; Phil Lee; In-Young Choi
Journal:  Neurochem Res       Date:  2015-11-26       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.